Clinical Chemistry II Practice Test

The main idea here is that the multitarget stool DNA test looks for multiple kinds of signals in stool that together indicate colorectal neoplasia. It combines detection of DNA mutations linked to colorectal cancer and other tumor-associated changes, with cancer biomarkers (such as methylation markers) that reflect abnormal cellular activity, and it also checks for the presence of occult blood by measuring hemoglobin. Seeing these diverse targets in a single test increases the likelihood of detecting cancers or precancerous polyps without relying on imaging studies. It’s different from tests that look only for blood or only for imaging, because this test uses both genetic/biomarker signals and blood presence from the stool to screen for disease. If the test comes back positive, a follow-up colonoscopy is typically recommended for a definitive diagnosis.